These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30570365)

  • 1. Nano-carriers for drug routeing - towards a new era.
    Lakkireddy HR; Bazile DV
    J Drug Target; 2019; 27(5-6):525-541. PubMed ID: 30570365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
    Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
    Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
    Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Oral Nano-Antibiotics for Bacterial Infection Therapy.
    Wu ZL; Zhao J; Xu R
    Int J Nanomedicine; 2020; 15():9587-9610. PubMed ID: 33293809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catan-ionic hybrid lipidic nano-carriers for enhanced bioavailability and anti-tumor efficacy of chemodrugs.
    Liu B; He D; Wu J; Sun Q; Zhang M; Tan Q; Li Y; Zhang J
    Oncotarget; 2017 May; 8(19):30922-30932. PubMed ID: 28427235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart branched polymer drug conjugates as nano-sized drug delivery systems.
    Duro-Castano A; Movellan J; Vicent MJ
    Biomater Sci; 2015 Oct; 3(10):1321-34. PubMed ID: 26266272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-Based Drug Delivery and Use of Nano-and Microcarriers for Cell Functionalization.
    Timin AS; Litvak MM; Gorin DA; Atochina-Vasserman EN; Atochin DN; Sukhorukov GB
    Adv Healthc Mater; 2018 Feb; 7(3):. PubMed ID: 29193876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
    George A; Shah PA; Shrivastav PS
    Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
    Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
    Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern.
    Lam PL; Wong WY; Bian Z; Chui CH; Gambari R
    Nanomedicine (Lond); 2017 Feb; 12(4):357-385. PubMed ID: 28078952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Preparative Approaches for Micro and Nano Drug Delivery Carriers.
    Bochicchio S; Dalmoro A; Barba AA; d'Amore M; Lamberti G
    Curr Drug Deliv; 2017; 14(2):203-215. PubMed ID: 27364732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-sized Droplets of Self-Emulsifying System for Enhancing Oral Bioavailability of Chemotherapeutic Agent VP-16 in Rats: A Nano Lipid Carrier for BCS Class IV Drugs.
    Khalid N; Sarfraz M; Arafat M; Akhtar M; Löbenberg R; Ur Rehman N
    J Pharm Pharm Sci; 2018; 21(1):398-408. PubMed ID: 30365396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Trends in Clinical Trials Related to Carrier-Based Drugs.
    Tagami T; Ozeki T
    J Pharm Sci; 2017 Sep; 106(9):2219-2226. PubMed ID: 28259767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-Drug Conjugate for Enhancing Drug Delivery.
    Irby D; Du C; Li F
    Mol Pharm; 2017 May; 14(5):1325-1338. PubMed ID: 28080053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the salting-out technique on the preparation of colloidal particulate systems for pharmaceutical applications.
    Mendoza-Muñoz N; Quintanar-Guerrero D; Allémann E
    Recent Pat Drug Deliv Formul; 2012 Dec; 6(3):236-49. PubMed ID: 22734871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders.
    Mazibuko Z; Choonara YE; Kumar P; Du Toit LC; Modi G; Naidoo D; Pillay V
    J Pharm Sci; 2015 Apr; 104(4):1213-29. PubMed ID: 25559087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers.
    Rabanel JM; Aoun V; Elkin I; Mokhtar M; Hildgen P
    Curr Med Chem; 2012; 19(19):3070-102. PubMed ID: 22612696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.